Skip to content

Atherosclerotic risk factors and their interactions with immunmodulatory therapies in patients with psoriasis

Atherosclerotic risk factors and their interactions with immunmodulatory therapies in patients with psoriasis - ARMENIA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035332
Enrollment
500
Registered
2024-12-30
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0

Interventions

Group 1: Patients with psoriasis in outpatient care. During the waiting time for routine examinations in dermatological outpatient psoriasis consultations, patients are informed about the study and a

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients: - Written consent of the patient before filling out the questionnaire - Patient is capable of giving consent and able to understand the clinical trial - Age >18 years - Confirmed psoriasis (all subtypes) Physicians - Written consent of the treating physicians - Approved physician - Practitioners of patients with psoriasis (specialty: dermatology, rheumatology, general medicine) - Age =18 years

Exclusion criteria

Exclusion criteria: - Lack of capacity to consent / No consent - Rejection by patients

Design outcomes

Primary

MeasureTime frame
Awareness of patients with psoriasis and physicians in outpatient care regarding increased cardiovascular risks in patients with psoriasis, determined by questionnaires.

Secondary

MeasureTime frame
Among other things: - Differences in awareness within different sozio-demographic groups - Differences in different medical specialties - Factors influencing the awareness behavior of physicians about the increased risk

Countries

Germany

Contacts

Public ContactSebastian Spethmann

Klinik für Kardiologie, Angiologie und Intensivmedizin

sebastian.spethmann@dhzc-charite.de030 450 613235

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026